Skip to main content

Advertisement

Articles

Page 37 of 37

  1. The metabolic syndrome is a highly prevalent clinical entity. The recent Adult Treatment Panel (ATP III) guidelines have called specific attention to the importance of targeting the cardiovascular risk factors...

    Authors: Alexander Tenenbaum, Enrique Z Fisman and Michael Motro

    Citation: Cardiovascular Diabetology 2003 2:4

    Content type: Review

    Published on:

  2. Coronary plaque rupture may result from localised over expression of matrix metalloproteinases (MMPs) within the plaque by infiltrating monocyte – macrophages. As MMP expression can be promoted by the modified...

    Authors: Mark D Baugh, Jelena Gavrilovic, Isabel R Davies, David A Hughes and Mike J Sampson

    Citation: Cardiovascular Diabetology 2003 2:3

    Content type: Original investigation

    Published on:

  3. Cardiovascular disease accounts for at least 85 percent of deaths for those patients with type 2 diabetes mellitus (T2DM). Additionally, 75 percent of these deaths are due to ischemic heart disease.

    Authors: Melvin R Hayden and Suresh C Tyagi

    Citation: Cardiovascular Diabetology 2003 2:2

    Content type: Hypothesis

    Published on:

  4. Our aim is to summarize and discuss the recent literature linking diabetes mellitus with heart failure, and to address the issue of the optimal treatment for diabetic patients with heart failure.

    Authors: Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire and Pascal de Groote

    Citation: Cardiovascular Diabetology 2003 2:1

    Content type: Review

    Published on:

  5. There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolip...

    Authors: Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone and Pietro Fratino

    Citation: Cardiovascular Diabetology 2002 1:5

    Content type: Original investigation

    Published on:

  6. The increase in the prevalence of insulin resistance-related metabolic syndrome, a disorder that greatly increases the risk of diabetes, heart attack and stroke, is alarming. One of the most frequent and early...

    Authors: Radka Lichnovská, Simona Gwozdziewiczová and Jirí Hrebícek

    Citation: Cardiovascular Diabetology 2002 1:4

    Content type: Original investigation

    Published on:

  7. Metabolic syndrome, insulin resistance, prediabetes, and overt type 2 diabetes mellitus are associated with an accelerated atherosclerosis (atheroscleropathy). This quartet is also associated with multiple met...

    Authors: Melvin R Hayden and Suresh C Tyagi

    Citation: Cardiovascular Diabetology 2002 1:3

    Content type: Review

    Published on:

  8. The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed ...

    Authors: Enrique Z Fisman, Alexander Tenenbaum and Michael Motro

    Citation: Cardiovascular Diabetology 2002 1:2

    Content type: Commentary

    Published on:

Annual Journal Metrics

Advertisement